companydata.dkcompanydata.dk

NORDIC BIOTECH ADVISORS ApS: Financial statements 2014

CVR: 26123925

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

NORDIC BIOTECH ADVISORS ApS (CVR 26123925) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 2,807,599 and a net result of DKK -161,863 compared with DKK 9,437 the year before. That is a decrease of 20.9% compared with the year before. Equity in the 2014 report amounted to DKK 1,213,059. The solvency ratio was 63.6%.

Gross Profit
DKK 2,807,599
Profit/Loss
DKK -161,863
Equity
DKK 1,213,059
Total Assets
DKK 1,908,184

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-2.8M-162K1.2M-
2013-3.6M9K1.4M-
2012-3.8M-63K1.4M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

NORDIC BIOTECH ADVISORS ApS: The 2013 annual report is outJun 24, 2014

NORDIC BIOTECH ADVISORS ApS has published its annual report for 2013. Gross profit came to DKK 3,550,848, and the net result was DKK 9,437.

NORDIC BIOTECH ADVISORS ApS appoints new auditorJun 20, 2014

As of June 20, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NORDIC BIOTECH ADVISORS ApS.

Auditor steps down at NORDIC BIOTECH ADVISORS ApSJun 20, 2014

As of June 20, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH ADVISORS ApS.

About NORDIC BIOTECH ADVISORS ApS

NORDIC BIOTECH ADVISORS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is registered under the industry Andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring. The company was previously named NEXGEN BIOTECH ApS and NORDIC BIOTECH ApS. The management consists of Florian Schønharting. The board consists of Florian Schønharting and Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS, C. HANSEN INVEST ApS and BVF/Nexgen Biotech, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,273,154 and a net result of DKK 360,368 compared with DKK -572,578 the year before. Equity in the 2025 report amounted to DKK 4,622,219.

Source: annual report 2025, Danish Business Authority